Rapid advances in technology and high disease burden worldwide are anticipated to proliferate animal vaccines market share at a considerable pace over 2019-2025.
Rapid advances in technology and high disease burden worldwide are anticipated to proliferate animal vaccines market share at a considerable pace over 2019-2025.
The global market has witnessed an accelerated development of new animal vaccination methods including nasal delivery, air-driven vaccine that can be penetrated through the skin of cats. This mode of treatment significantly prevents the occurrence of cancer at the injection site.
Likewise, increasing adoption of pets as companions will become a key driver expanding the industry trends over the estimated timeline. According to reliable statistics, over 75 million homes in Europe owned pets in 2014.
Furthermore, escalating animal farming, coupled with a strong focus on safeguarding animal health, is anticipated to amplify overall market growth in the foreseeable future.
As per authentic reports, the global animal vaccines market size is expected to surpass $9 billion by 2025.
High focus on welfare and protection of food-producing farm animals
In terms of segmentation by animal type, the farm animal vaccines segment is set to register remuneration of $6,509.6 million by 2025. The segmental growth is attributable to high awareness about animal health, along with mounting demand for risk-free foods and animal proteins from consumers.
Farm animals are highly susceptible to diseases caused by parasites, fungi, viruses, and bacteria. There has been an increased focus on reducing the disease burden to such animals, with vaccination being a crucial option for the welfare of these food-producing animals. Rapid development of different types of animal vaccines will benefit these farmed animals and contribute to safe and affordable food production.
Based on technology, the animal vaccines market from the toxoid vaccines segment is poised to depict a 4.8% CAGR through 2025, driven by its myriad usage benefits such as enhanced safety and efficacy.
Injection vaccines segment to observe major upsurge due to zoonotic disease prevalence
With regards to the infections spectrum, the viral vaccines segment recorded revenue of $3,792.4 million in 2018, which can be credited to the rising prevalence of viral infections such as influenza and Newcastle’s disease.
On the other hand, in terms of segmentation by route of administration, the animal vaccines market from the injection vaccines segment is projected to exhibit a CAGR of 4.3% through 2025. The segmental growth is due to the advantages associated with this administration model, such as the rapid onset of immunity, as well as high incidences of zoonotic diseases.
To access sample pages of this report titled, “Animal Vaccines Market Size By Animal Type (Farm Animal Vaccines {Poultry Vaccines, Cattle Vaccines, Swine Vaccines, Equine Vaccines, Aquaculture Vaccines}, Companion Animal Vaccines {Dog Vaccines, Cat Vaccines}), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Infections (Bacterial Vaccines, Viral Vaccines, Parasitic Vaccines, Fungal Vaccines), By Route of Administration (Injection Vaccines, Oral Vaccines, Immersion/Spray Vaccines), Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/3117
Rising consumption of animal-sourced protein in Germany
From a regional perspective, the Germany animal vaccines industry is anticipated to record a $432.6 million revenue by 2025, as a result of the increasing consumption of animal-sourced protein, alongside rising efforts of the government to develop and launch vaccines for animals.
In addition, the Japan animal vaccines market is set to depict a 10% CAGR through 2025, which can be attributed to the growing intake of meat and subsequent rise in need for animal farming in the region. Moreover, mandatory vaccination programs for cattle, swine, and poultry will considerably add impetus to the regional market outlook over the coming years.
Key animal vaccines market players include Zoetis, Neogen Corporation, Merck Animal Health, Henry Schein Animal Health, Elanco, Dechra Pharmaceuticals, Ceva Sante Animale, and Boehringer Ingelheim Animal Health, among others. These firms are focusing on strengthening their market position through varied strategies such as innovative product launches and mergers & acquisitions.
For instance, in January 2020, the U.S. Animal Health Business of Boehringer Ingelheim launched a vaccine, VAXXITEK® HVT+IBD+ND, which was designed to boost the immune foundation as well as optimize protection of poultry against diseases, namely Newcastle Disease, Infectious Bursal Disease, and Marek’s Disease.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com